Recruitment of CREB1 and Histone Deacetylase 2 (HDAC2) to the Mouse Ltbp-1 Promoter Regulates its Constitutive Expression in a Dioxin Receptor-dependent Manner

Journal of Molecular Biology

Volumn 380, Issue 1, 2008, Pages 1-16

  Gomez Duran, Aurea ^a   Ballestar, Esteban ^b   Carvajal Gonzalez, Jose M ^a   Marlowe, Jennifer L ^c   Puga, Alvaro ^c   Esteller, Manel ^b   Fernandez Salguero, Pedro M ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b Centro Nacional de Investigaciones Oncológicas   (Spain)

^c UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

CREB1; dioxin receptor; HDAC2; LTBP 1; transcriptional regulation

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 4; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN;

ACETYLATION; ANIMAL CELL; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EPIGENETICS; GENE OVEREXPRESSION; GENE REPRESSION; MOLECULAR CLONING; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; REGULATORY MECHANISM; REPRESSOR GENE; RNA INTERFERENCE; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION;

EID: 44649145793     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2008.04.056     Document Type: Article

References (66)

1. Massague J., and Chen Y.G. Controlling TGF-beta signaling. Genes Dev. 14 (2000) 627-644
2. Saharinen J., Hyytiainen M., Taipale J., and Keski-Oja J. Latent transforming growth factor-beta binding proteins (LTBPs) - structural extracellular matrix proteins for targeting TGF-beta action. Cytokine Growth Factor Rev. 10 (1999) 99-117
3. Massague J., Blain S.W., and Lo R.S. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103 (2000) 295-309
4. Siegel P.M., and Massague J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nature Rev. Cancer 3 (2003) 807-821
5. Annes J.P., Munger J.S., and Rifkin D.B. Making sense of latent TGFbeta activation. J. Cell Sci. 116 (2003) 217-224
6. Koli K., Saharinen J., Hyytiainen M., Penttinen C., and Keski-Oja J. Latency, activation, and binding proteins of TGF-beta. Microsc. Res. Tech. 52 (2001) 354-362
7. Lawrence D.A. Latent-TGF-beta: an overview. Mol. Cell Biochem. 219 (2001) 163-170
8. Dallas S.L., Rosser J.L., Mundy G.R., and Bonewald L.F. Proteolysis of latent transforming growth factor-beta (TGF-beta)-binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-beta from bone matrix. J. Biol. Chem. 277 (2002) 21352-21360
9. Oklu R., and Hesketh R. The latent transforming growth factor beta binding protein (LTBP) family. Biochem. J. 352 (2000) 601-610
10. Taipale J., and Keski-Oja J. Growth factors in the extracellular matrix. FASEB J. 11 (1997) 51-59
11. Giltay R., Kostka G., and Timpl R. Sequence and expression of a novel member (LTBP-4) of the family of latent transforming growth factor-beta binding proteins. FEBS Lett. 411 (1997) 164-168
12. Koski C., Saharinen J., and Keski-Oja J. Independent promoters regulate the expression of two amino terminally distinct forms of latent transforming growth factor-beta binding protein-1 (LTBP-1) in a cell type-specific manner. J. Biol. Chem. 274 (1999) 32619-32630
13. Moren A., Olofsson A., Stenman G., Sahlin P., Kanzaki T., Claesson-Welsh L., et al. Identification and characterization of LTBP-2, a novel latent transforming growth factor-beta-binding protein. J. Biol. Chem. 269 (1994) 32469-32478
14. Saharinen J., Taipale J., Monni O., and Keski-Oja J. Identification and characterization of a new latent transforming growth factor-beta-binding protein, LTBP-4. J. Biol. Chem. 273 (1998) 18459-18469
15. Tsuji T., Okada F., Yamaguchi K., and Nakamura T. Molecular cloning of the large subunit of transforming growth factor type beta masking protein and expression of the mRNA in various rat tissues. Proc. Natl Acad. Sci. USA 87 (1990) 8835-8839
16. Yin W., Smiley E., Germiller J., Mecham R.P., Florer J.B., Wenstrup R.J., and Bonadio J. Isolation of a novel latent transforming growth factor-beta binding protein gene (LTBP-3). J. Biol. Chem. 270 (1995) 10147-10160
17. Noguera I., Obata H., Gualandris A., Cowin P., and Rifkin D.B. Molecular cloning of the mouse Ltbp-1 gene reveals tissue specific expression of alternatively spliced forms. Gene 308 (2003) 31-41
18. Weiskirchen R., Moser M., Gunther K., Weiskirchen S., and Gressner A.M. The murine latent transforming growth factor-beta binding protein (Ltbp-1) is alternatively spliced, and maps to a region syntenic to human chromosome 2p21-22. Gene 308 (2003) 43-52
19. Hankinson O. The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 35 (1995) 307-340
20. Nebert D.W., Dalton T.P., Okey A.B., and Gonzalez F.J. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J. Biol. Chem. 279 (2004) 23847-23850
21. Nebert D.W., Roe A.L., Dieter M.Z., Solis W.A., Yang Y., and Dalton T.P. Role of the aromatic hydrocarbon receptor and Ah gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem. Pharmacol. 59 (2000) 65-85
22. Schmidt J.V., and Bradfield C.A. Ah receptor signaling pathways. Annu. Rev. Cell Dev. Biol. 12 (1996) 55-89
23. Rivera S.P., Saarikoski S.T., and Hankinson O. Identification of a novel dioxin-inducible cytochrome P450. Mol. Pharmacol. 61 (2002) 255-259
24. Marlowe J.L., and Puga A. Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis. J. Cell. Biochem. 96 (2005) 1174-1184
25. Elferink C.J. Aryl hydrocarbon receptor-mediated cell cycle control. Prog. Cell Cycle Res. 5 (2003) 261-267
26. Puga A., Tomlinson C.R., and Xia Y. Ah receptor signals cross-talk with multiple developmental pathways. Biochem. Pharmacol. 69 (2005) 199-207
27. Bock K.W., and Kohle C. Ah receptor: dioxin-mediated toxic responses as hints to deregulated physiologic functions. Biochem. Pharmacol. 72 (2006) 393-404
28. Barouki R., Coumoul X., and Fernandez-Salguero P.M. The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein. FEBS Lett. 581 (2007) 3608-3615
29. Frericks M., Meissner M., and Esser C. Microarray analysis of the AHR system: tissue-specific flexibility in signal and target genes. Toxicol. Appl. Pharmacol. 220 (2007) 320-332
30. Frericks M., Temchura V.V., Majora M., Stutte S., and Esser C. Transcriptional signatures of immune cells in aryl hydrocarbon receptor (AHR)-proficient and AHR-deficient mice. Biol. Chem. 387 (2006) 1219-1226
31. Tijet N., Boutros P.C., Moffat I.D., Okey A.B., Tuomisto J., and Pohjanvirta R. Aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries. Mol. Pharmacol. 69 (2006) 140-153
32. Ogi T., Mimura J., Hikida M., Fujimoto H., Fujii-Kuriyama Y., and Ohmori H. Expression of human and mouse genes encoding polkappa: testis-specific developmental regulation and AhR-dependent inducible transcription. Genes Cells 6 (2001) 943-953
33. Kolluri S.K., Balduf C., Hofmann M., and Gottlicher M. Novel target genes of the Ah (dioxin) receptor: transcriptional induction of N-myristoyltransferase 2. Cancer Res. 61 (2001) 8534-8539
34. Kolluri S.K., Weiss C., Koff A., and Gottlicher M. p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. Genes Dev. 13 (1999) 1742-1753
35. Matikainen T., Perez G.I., Jurisicova A., Pru J.K., Schlezinger J.J., Ryu H.Y., et al. Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals. Nature Genet. 28 (2001) 355-360
36. Niermann T., Schmutz S., Erne P., and Resink T. Aryl hydrocarbon receptor ligands repress T-cadherin expression in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 300 (2003) 943-949
37. Yang X., Liu D., Murray T.J., Mitchell G.C., Hesterman E.V., Karchner S.I., et al. The aryl hydrocarbon receptor constitutively represses c-myc transcription in human mammary tumor cells. Oncogene 24 (2005) 7869-7881
38. Marlowe J.L., Knudsen E.S., Schwemberger S., and Puga A. The aryl hydrocarbon receptor displaces p300 from E2F-dependent promoters and represses S phase-specific gene expression. J. Biol. Chem. 279 (2004) 29013-29022
39. Denison M.S., and Whitlock Jr. J.P. Xenobiotic-inducible transcription of cytochrome P450 genes. J. Biol. Chem. 270 (1995) 18175-18178
40. Whitlock Jr. J.P. Induction of cytochrome P4501A1. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 103-125
41. Peterson T.C., Hodgson P., Fernandez-Salguero P., Neumeister M., and Gonzalez F.J. Hepatic fibrosis and cytochrome P450: experimental models of fibrosis compared to AHR knockout mice. Hepatol. Res. 17 (2000) 112-125
42. Fernandez-Salguero P., Pineau T., Hilbert D.M., McPhail T., Lee S.S., Kimura S., et al. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 268 (1995) 722-726
43. Corchero J., Martin-Partido G., Dallas S.L., and Fernandez-Salguero P.M. Liver portal fibrosis in dioxin receptor-null mice that overexpress the latent transforming growth factor-beta-binding protein-1. Int. J. Expt. Pathol. 85 (2004) 295-302
44. Elizondo G., Fernandez-Salguero P., Sheikh M.S., Kim G.Y., Fornace A.J., Lee K.S., and Gonzalez F.J. Altered cell cycle control at the G(2)/M phases in aryl hydrocarbon receptor-null embryo fibroblast. Mol. Pharmacol. 57 (2000) 1056-1063
45. Santiago-Josefat B., Mulero-Navarro S., Dallas S.L., and Fernandez-Salguero P.M. Overexpression of latent transforming growth factor-{beta} binding protein 1 (LTBP-1) in dioxin receptor-null mouse embryo fibroblasts. J. Cell Sci. 117 (2004) 849-859
46. Gomez-Duran A., Mulero-Navarro S., Chang X., and Fernandez-Salguero P.M. LTBP-1 blockade in dioxin receptor-null mouse embryo fibroblasts decreases TGF-beta activity: role of extracellular proteases plasmin and elastase. J. Cell. Biochem. 97 (2006) 380-392
47. Chang X., Fan Y., Karyala S., Schwemberger S., Tomlinson C.R., Sartor M.A., and Puga A. Ligand-independent regulation of transforming growth factor beta1 expression and cell cycle progression by the aryl hydrocarbon receptor. Mol. Cell Biol. 27 (2007) 6127-6139
48. Yang F., and Bleich D. Transcriptional regulation of cyclooxygenase-2 gene in pancreatic beta-cells. J. Biol. Chem. 279 (2004) 35403-35411
49. Matthews J., Wihlen B., Thomsen J., and Gustafsson J.A. Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters. Mol. Cell Biol. 25 (2005) 5317-5328
50. Fass D.M., Butler J.E., and Goodman R.H. Deacetylase activity is required for cAMP activation of a subset of CREB target genes. J. Biol. Chem. 278 (2003) 43014-43019
51. Wei Y.D., Tepperman K., Huang M.Y., Sartor M.A., and Puga A. Chromium inhibits transcription from polycyclic aromatic hydrocarbon-inducible promoters by blocking the release of histone deacetylase and preventing the binding of p300 to chromatin. J. Biol. Chem. 279 (2004) 4110-4119
52. Whitlock Jr. J.P., Okino S.T., Dong L., Ko H.P., Clarke-Katzenberg R., Ma Q., and Li H. Cytochromes P450 5: induction of cytochrome P4501A1: a model for analyzing mammalian gene transcription. FASEB J. 10 (1996) 809-818
53. Zaher H., Fernandez-Salguero P.M., Letterio J., Sheikh M.S., Fornace Jr. A.J., Roberts A.B., and Gonzalez F.J. The involvement of aryl hydrocarbon receptor in the activation of transforming growth factor-beta and apoptosis. Mol. Pharmacol. 54 (1998) 313-321
54. Kwok S., Qin L., Partridge N.C., and Selvamurugan N. Parathyroid hormone stimulation and PKA signaling of latent transforming growth factor-beta binding protein-1 (LTBP-1) mRNA expression in osteoblastic cells. J. Cell. Biochem. 95 (2005) 1002-1011
55. Gonzalez G.A., and Montminy M.R. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59 (1989) 675-680
56. Liu P.C., Dunlap D.Y., and Matsumura F. Suppression of C/EBPalpha and induction of C/EBPbeta by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mouse adipose tissue and liver. Biochem. Pharmacol. 55 (1998) 1647-1655
57. Vogel C.F., Sciullo E., Park S., Liedtke C., Trautwein C., and Matsumura F. Dioxin increases C/EBPbeta transcription by activating cAMP/protein kinase A. J. Biol. Chem. 279 (2004) 8886-8894
58. Canettieri G., Morantte I., Guzman E., Asahara H., Herzig S., Anderson S.D., et al. Attenuation of a phosphorylation-dependent activator by an HDAC-PP1 complex. Nature Struct. Biol. 10 (2003) 175-181
59. Ito K., Barnes P.J., and Adcock I.M. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol. Cell Biol. 20 (2000) 6891-6903
60. Tenbrock K., Juang Y.T., Leukert N., Roth J., and Tsokos G.C. The transcriptional repressor cAMP response element modulator alpha interacts with histone deacetylase 1 to repress promoter activity. J. Immunol. 177 (2006) 6159-6164
61. Nottebrock C., Riecke K., Kruse M., Shakibaei M., and Stahlmann R. Effects of 2,3,7,8-tetrachloro-dibenzo-p-dioxin on the extracellular matrix of the thymus in juvenile marmosets (Callithrix jacchus). Toxicology 226 (2006) 197-207
62. Riecke K., Grimm D., Shakibaei M., Kossmehl P., Schulze-Tanzil G., Paul M., and Stahlmann R. Low doses of 2,3,7,8-tetrachlorodibenzo-p-dioxin increase transforming growth factor beta and cause myocardial fibrosis in marmosets (Callithrix jacchus). Arch. Toxicol. 76 (2002) 360-366
63. Yang J.H., Vogel C., and Abel J. A malignant transformation of human cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin exhibits altered expressions of growth regulatory factors. Carcinogenesis 20 (1999) 13-18
64. Santiago-Josefat B., Pozo-Guisado E., Mulero-Navarro S., and Fernandez-Salguero P.M. Proteasome inhibition induces nuclear translocation and transcriptional activation of the dioxin receptor in mouse embryo primary fibroblasts in the absence of xenobiotics. Mol. Cell Biol. 21 (2001) 1700-1709
65. Legraverend C., Hannah R.R., Eisen H.J., Owens I.S., Nebert D.W., and Hankinson O. Regulatory gene product of the Ah locus. Characterization of receptor mutants among mouse hepatoma clones. J. Biol. Chem. 257 (1982) 6402-6407
66. Ropero S., Fraga M.F., Ballestar E., Hamelin R., Yamamoto H., Boix-Chornet M., et al. A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition. Nature Genet. 38 (2006) 566-569